Liquid biopsy at the frontier of kidney diseases: application of exosomes in diagnostics and therapeutics

E Agborbesong, J Bissler, X Li - Genes, 2023 - mdpi.com
In the era of precision medicine, liquid biopsy techniques, especially the use of urine
analysis, represent a paradigm shift in the identification of biomarkers, with considerable …

Future directions in optimizing anesthesia to reduce perioperative acute kidney injury

Y Liu, J Xu, L Niu, Y Wu, D Zhang, X Tang, Z Zhu… - Am J Nephrol, 2023 - karger.com
Background: Perioperative acute kidney injury (AKI) is common in surgical patients and is
associated with high morbidity and mortality. There are currently few options for AKI …

Exosomes Highlight Future Directions in the Treatment of Acute Kidney Injury

X Zhang, J Wang, J Zhang, Y Tan, Y Li… - International Journal of …, 2023 - mdpi.com
Acute kidney injury (AKI) is a severe health problem associated with high morbidity and
mortality rates. It currently lacks specific therapeutic strategies. This review focuses on the …

The role of small extracellular vesicle non-coding RNAs in kidney diseases

C Luo, H Liu, L Shao, J Tang, Q He, J Jin - Frontiers in genetics, 2022 - frontiersin.org
Kidney diseases have become an increasingly common public health concern worldwide.
The discovery of specific biomarkers is of substantial clinical significance in kidney disease …

LncRNA 152 attenuates lipopolysaccharide‐induced acute kidney injury in rats by regulating the FGF23/Klotho/MAPK axis

L Lei, S Zhang, R Hou, P Dong - Nephrology, 2023 - Wiley Online Library
Aim This study aimed to explore the effect and related mechanisms of LncRNA 152 in acute
kidney injury (AKI). Methods QRT‐PCR was used to detect the expression of LncRNA 152 …